Ribavirinum 6 [hp_C]/1
Ribavirinum · PELLET · Hahnemann Laboratories, INC.
Ribavirinum is an oral nucleoside analog antiviral medication available as an over-the-counter pellet form that works by interfering with viral replication to treat certain viral infections. It is commonly used to help treat conditions caused by viruses such as respiratory syncytial virus (RSV) and hepatitis C.
Key Facts
- Brand Name
- Ribavirinum
- Generic Name
- Ribavirinum
- NDC Code (Product)
37662-4136- Manufacturer
- Hahnemann Laboratories, INC.
- Strength
- 6 [hp_C]/1
- Dosage Form
- PELLET
- Route
- ORAL
- Marketing Status
- Drug Class
- Nucleoside Analog Antiviral [EPC]
- Marketing Start
- 10/12/2023
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Frequently Asked Questions
What is Ribavirinum used for?
Ribavirinum is an oral nucleoside analog antiviral medication available as an over-the-counter pellet form that works by interfering with viral replication to treat certain viral infections. It is commonly used to help treat conditions caused by viruses such as respiratory syncytial virus (RSV) and hepatitis C.
Is Ribavirinum a controlled substance?
Ribavirinum is not classified as a controlled substance by the DEA.
What is the generic name for Ribavirinum?
The generic name for Ribavirinum is Ribavirinum. There are no other listed brand versions of Ribavirinum.
What is the NDC code for Ribavirinum 6 [hp_C]/1?
The NDC (National Drug Code) for Ribavirinum 6 [hp_C]/1 is 37662-4136, listed by Hahnemann Laboratories, INC..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)